DaVita HealthCare Partner (DVA)
134.73
+23.54 (21.17%)
NYSE · Last Trade: Feb 4th, 3:34 AM EST
Detailed Quote
| Previous Close | 111.19 |
|---|---|
| Open | 128.00 |
| Bid | 133.61 |
| Ask | 135.15 |
| Day's Range | 125.00 - 139.86 |
| 52 Week Range | 101.00 - 178.47 |
| Volume | 4,809,666 |
| Market Cap | 9.51B |
| PE Ratio (TTM) | 13.90 |
| EPS (TTM) | 9.7 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 1,187,684 |
Chart
About DaVita HealthCare Partner (DVA)
DaVita HealthCare Partners is a leading provider of kidney care services in the United States, offering a comprehensive range of dialysis and related healthcare services for patients with chronic kidney failure and end-stage renal disease. The company operates a vast network of outpatient dialysis centers and provides integrated care management and support for patients through various healthcare services, including nutritional counseling, social services, and patient education. DaVita is committed to improving patient outcomes and enhancing the quality of life for those affected by kidney disease while working closely with healthcare providers, payers, and communities to address the evolving challenges of kidney care. Read More
News & Press Releases
Which S&P500 stocks are moving on Tuesday?chartmill.com
Via Chartmill · February 3, 2026
Top movers analysis one hour before the close of the markets on 2026-02-03: top gainers and losers in today's session.chartmill.com
Via Chartmill · February 3, 2026
The market now seems to realize it may have misjudged this company's future.
Via The Motley Fool · February 3, 2026
Shares of dialysis provider DaVita Inc. (NYSE:DVA)
jumped 25.3% in the morning session after the company reported fourth-quarter results that topped Wall Street's expectations and issued a robust earnings forecast for 2026.
Via StockStory · February 3, 2026
DaVita Inc (NYSE:DVA) Stock Surges 15% After Q4 2025 Earnings Beatchartmill.com
Via Chartmill · February 2, 2026
Top gainers and losers in the S&P500 index during Monday's after-hours session.chartmill.com
Via Chartmill · February 2, 2026
Uncover the latest developments among S&P500 stocks in today's session.chartmill.com
Via Chartmill · February 3, 2026
What's going on in today's sessionchartmill.com
Via Chartmill · February 3, 2026
These S&P500 stocks are gapping in today's sessionchartmill.com
Via Chartmill · February 3, 2026
Tuesday's session: gap up and gap down stockschartmill.com
Via Chartmill · February 3, 2026
DaVita (DVA) Q4 2025 Earnings Call Transcript
Via The Motley Fool · February 3, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) reported Q4 CY2025 results exceeding the market’s revenue expectations, with sales up 9.9% year on year to $3.62 billion. Its non-GAAP profit of $3.40 per share was 6.5% above analysts’ consensus estimates.
Via StockStory · February 3, 2026
These S&P500 stocks are moving in today's pre-market sessionchartmill.com
Via Chartmill · February 3, 2026
DaVita said its integrated kidney care unit hit full-year profitability in 2025, a year ahead of its original 2026 target.
Via Stocktwits · February 2, 2026
Dialysis provider DaVita Inc. (NYSE:DVA) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 9.9% year on year to $3.62 billion. Its non-GAAP profit of $3.40 per share was 6.5% above analysts’ consensus estimates.
Via StockStory · February 2, 2026
Elara Caring (Elara), a leading national provider of skilled home health, hospice, behavioral health, and personal care services, today announced that it has entered into an agreement for a strategic investment from Ares’ Private Equity Group (Ares) and DaVita. The investment is intended to expand access to personalized, clinically advanced care at home for patients with complex and acute needs. Elara will continue to operate as a wholly independent company led by CEO Ananth Mohan and the current management team. Following the closing, the parties will collaborate to help Elara expand access to care through new care models and clinical programs.
By Elara Caring · Via Business Wire · February 2, 2026
Dialysis provider DaVita Inc. (NYSE:DVA)
will be reporting earnings this Monday after the bell. Here’s what you need to know.
Via StockStory · January 31, 2026
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Those leading the charge have not only realized strong financial performance but also propelled the broader industry’s returns
as healthcare stocks have gained 17.4% over the past six months while the S&P 500 was up 9.6%.
Via StockStory · January 29, 2026
Date: January 28, 2026 The landscape of American managed care is currently undergoing a seismic shift, and perhaps no company exemplifies this transformation—and the accompanying volatility—more than Humana Inc. (NYSE: HUM). Long considered the "pure-play" leader in Medicare Advantage (MA), Humana finds itself at a critical juncture. As of today, January 28, 2026, the company [...]
Via Finterra · January 28, 2026
While strong cash flow is a key indicator of stability, it doesn’t always translate to superior returns.
Some cash-heavy businesses struggle with inefficient spending, slowing demand, or weak competitive positioning.
Via StockStory · January 22, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · January 13, 2026
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor.
The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.
Via StockStory · January 11, 2026
These S&P500 stocks are moving in today's sessionchartmill.com
Via Chartmill · January 9, 2026
Berkshire's closely watched equity portfolio has a new portfolio manager with big shoes to fill.
Via The Motley Fool · January 7, 2026
Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages.
Just because a business is in the green today doesn’t mean it will thrive tomorrow.
Via StockStory · December 28, 2025